Immuno-Oncology Market Size, Share, Growth, and Industry Analysis, By Types (Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines, Oncolytic Virus) , Applications (Hospitals, Clinics, Ambulatory Surgical Centers) and Regional Insights and Forecast to 2033

Detailed TOC of Global Immuno-Oncology Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2025-2033

Table of Content

1 Immuno-Oncology Market Overview
1.1 Product Overview
1.2 Market Segmentation
1.2.1 Market by Types
1.2.2 Market by Applications
1.2.3 Market by Regions
1.3 Global Immuno-Oncology Market Size (2018-2033)
1.3.1 Global Immuno-Oncology Revenue ($) and Growth Rate (2018-2033)
1.3.2 Global Immuno-Oncology Sales Volume and Growth Rate (2018-2033)
1.4 Research Method and Logic
1.4.1 Research Method
1.4.2 Research Data Source

2 Global Immuno-Oncology Market Historic Revenue ($) and Sales Volume Segment by Type
2.1 Global Immuno-Oncology Historic Revenue ($) by Type (2018-2025)
2.2 Global Immuno-Oncology Historic Sales Volume by Type (2018-2025)
2.3 Immune Checkpoint Inhibitors Sales and Price (2018-2025)
2.4 Immune System Modulators Sales and Price (2018-2025)
2.5 Cancer Vaccines Sales and Price (2018-2025)
2.6 Oncolytic Virus Sales and Price (2018-2025)

3 Global Immuno-Oncology Historic Revenue ($) and Sales Volume by Application (2018-2025)
3.1 Global Immuno-Oncology Historic Revenue ($) by Application (2018-2025)
3.2 Global Immuno-Oncology Historic Sales Volume by Application (2018-2025)
3.3 Hospitals Sales, Revenue and Growth Rate (2018-2025)
3.4 Clinics Sales, Revenue and Growth Rate (2018-2025)
3.5 Ambulatory Surgical Centers Sales, Revenue and Growth Rate (2018-2025)

4 Market Dynamic and Trends
4.1 Industry Development Trends under Global Inflation
4.2 Impact of Russia and Ukraine War
4.3 Driving Factors for Immuno-Oncology Market
4.4 Factors Challenging the Market
4.5 Opportunities
4.6 Risk Analysis
4.7 Industry News and Policies by Regions
4.7.1 Immuno-Oncology Industry News
4.7.2 Immuno-Oncology Industry Policies

5 Global Immuno-Oncology Market Revenue ($) and Sales Volume by Major Regions
5.1 Global Immuno-Oncology Sales Volume by Region (2018-2025)
5.2 Global Immuno-Oncology Market Revenue ($) by Region (2018-2025)

6 Global Immuno-Oncology Import Volume and Export Volume by Major Regions
6.1 Global Immuno-Oncology Import Volume by Region (2018-2025)
6.2 Global Immuno-Oncology Export Volume by Region (2018-2025)

7 North America Immuno-Oncology Market Current Status (2018-2025)
7.1 Overall Market Size Analysis (2018-2025)
7.1.1 North America Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
7.1.2 North America Immuno-Oncology Sales Volume and Growth Rate (2018-2025)
7.2 North America Immuno-Oncology Market Trends Analysis Under Global Inflation
7.3 North America Immuno-Oncology Sales Volume and Revenue ($) by Country (2018-2025)
7.4 United States
7.4.1 United States Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
7.5 Canada
7.5.1 Canada Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)

8 Asia Pacific Immuno-Oncology Market Current Status (2018-2025)
8.1 Overall Market Size Analysis (2018-2025)
8.1.1 Asia Pacific Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
8.1.2 Asia Pacific Immuno-Oncology Sales Volume and Growth Rate (2018-2025)
8.2 Asia Pacific Immuno-Oncology Market Trends Analysis Under Global Inflation
8.3 Asia Pacific Immuno-Oncology Sales Volume and Revenue ($) by Country (2018-2025)
8.4 China
8.4.1 China Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
8.5 Japan
8.5.1 Japan Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
8.6 India
8.6.1 India Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
8.7 South Korea
8.7.1 South Korea Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
8.8 Southeast Asia
8.8.1 Southeast Asia Immuno-Oncology Revenue ($) by Country (2018-2025)
8.9 Australia
8.9.1 Australia Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)

9 Europe Immuno-Oncology Market Current Status (2018-2025)
9.1 Overall Market Size Analysis (2018-2025)
9.1.1 Europe Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
9.2.1 Europe Immuno-Oncology Sales Volume and Growth Rate (2018-2025)
9.2 Europe Immuno-Oncology Market Trends Analysis Under Global Inflation
9.3 Europe Immuno-Oncology Sales Volume and Revenue ($) by Country (2018-2025)
9.4 Germany
9.4.1 Germany Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
9.5 France
9.5.1 France Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
9.6 United Kingdom
9.6.1 United Kingdom Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
9.7 Italy
9.7.1 Italy Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
9.8 Spain
9.8.1 Spain Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
9.9 Russia
9.9.1 Russia Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
9.10 Poland
9.10.1 Poland Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)

10 Latin America Immuno-Oncology Market Current Status (2018-2025)
10.1 Overall Market Size Analysis (2018-2025)
10.1.1 Latin America Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
10.1.2 Latin America Immuno-Oncology Sales Volume and Growth Rate (2018-2025)
10.2 Latin America Immuno-Oncology Market Trends Analysis Under Global Inflation
10.3 Latin America Immuno-Oncology Sales Volume and Revenue ($) by Country (2018-2025)
10.4 Mexico
10.4.1 Mexico Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
10.5 Brazil
10.5.1 Brazil Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
10.6 Argentina
10.6.1 Argentina Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)

11 Middle East and Africa Immuno-Oncology Market Current Status (2018-2025)
11.1 Overall Market Size Analysis (2018-2025)
11.1.1 Middle East and Africa Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
11.2.1 Middle East and Africa Immuno-Oncology Sales Volume and Growth Rate (2018-2025)
11.2 Middle East and Africa Immuno-Oncology Market Trends Analysis Under Global Inflation
11.3 Middle East and Africa Immuno-Oncology Sales Volume and Revenue ($) by Country (2018-2025)
11.4 GCC Countries
11.4.1 GCC Countries Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)
11.5 Africa
11.5.1 Africa Immuno-Oncology Revenue ($) and Growth Rate (2018-2025)

12 Market Competition Analysis and Key Companies Profiles
12.1 Market Competition by Key Players
12.1.1 Global Immuno-Oncology Revenue ($) and Market Share of Key Players
12.1.2 Global Immuno-Oncology Sales Volume and Market Share of Key Players
12.1.3 Global Immuno-Oncology Average Price by Players
12.1.4 Mergers & Acquisitions, Expansion
12.2 Johnson & Johnson Market Performance and Business Analysis
12.2.1 Company Profiles
12.2.2 Product Profiles and Application
12.2.3 Johnson & Johnson Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.3 ImmunoCellular Therapeutics Market Performance and Business Analysis
12.3.1 Company Profiles
12.3.2 Product Profiles and Application
12.3.3 ImmunoCellular Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.4 Celldex Therapeutics Market Performance and Business Analysis
12.4.1 Company Profiles
12.4.2 Product Profiles and Application
12.4.3 Celldex Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.5 Merck & Co. Market Performance and Business Analysis
12.5.1 Company Profiles
12.5.2 Product Profiles and Application
12.5.3 Merck & Co. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.6 EMD Serono Market Performance and Business Analysis
12.6.1 Company Profiles
12.6.2 Product Profiles and Application
12.6.3 EMD Serono Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.7 Galena Biopharma Market Performance and Business Analysis
12.7.1 Company Profiles
12.7.2 Product Profiles and Application
12.7.3 Galena Biopharma Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.8 Sanofi S.A. Market Performance and Business Analysis
12.8.1 Company Profiles
12.8.2 Product Profiles and Application
12.8.3 Sanofi S.A. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.9 AbbVie Market Performance and Business Analysis
12.9.1 Company Profiles
12.9.2 Product Profiles and Application
12.9.3 AbbVie Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.10 Prometheus Therapeutics & Diagnostics Market Performance and Business Analysis
12.10.1 Company Profiles
12.10.2 Product Profiles and Application
12.10.3 Prometheus Therapeutics & Diagnostics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.11 Hoffmann-La Roche AG Market Performance and Business Analysis
12.11.1 Company Profiles
12.11.2 Product Profiles and Application
12.11.3 Hoffmann-La Roche AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.12 Incyte Market Performance and Business Analysis
12.12.1 Company Profiles
12.12.2 Product Profiles and Application
12.12.3 Incyte Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.13 Bristol-Myers Squibb Market Performance and Business Analysis
12.13.1 Company Profiles
12.13.2 Product Profiles and Application
12.13.3 Bristol-Myers Squibb Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.14 Amgen, Inc Market Performance and Business Analysis
12.14.1 Company Profiles
12.14.2 Product Profiles and Application
12.14.3 Amgen, Inc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.15 Bavarian Nordic Market Performance and Business Analysis
12.15.1 Company Profiles
12.15.2 Product Profiles and Application
12.15.3 Bavarian Nordic Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.16 Eli Lilly and Company Market Performance and Business Analysis
12.16.1 Company Profiles
12.16.2 Product Profiles and Application
12.16.3 Eli Lilly and Company Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.17 Celgene Corporation Market Performance and Business Analysis
12.17.1 Company Profiles
12.17.2 Product Profiles and Application
12.17.3 Celgene Corporation Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.18 Aduro BioTech Market Performance and Business Analysis
12.18.1 Company Profiles
12.18.2 Product Profiles and Application
12.18.3 Aduro BioTech Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.19 Pfizer Inc. Market Performance and Business Analysis
12.19.1 Company Profiles
12.19.2 Product Profiles and Application
12.19.3 Pfizer Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.20 AstraZeneca, Plc Market Performance and Business Analysis
12.20.1 Company Profiles
12.20.2 Product Profiles and Application
12.20.3 AstraZeneca, Plc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.21 Gilead Sciences Inc. Market Performance and Business Analysis
12.21.1 Company Profiles
12.21.2 Product Profiles and Application
12.21.3 Gilead Sciences Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.22 Novartis International AG Market Performance and Business Analysis
12.22.1 Company Profiles
12.22.2 Product Profiles and Application
12.22.3 Novartis International AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)

13 Value Chain of the Immuno-Oncology Market
13.1 Value Chain Status
13.1.1 Value Chain Status Under Global Inflation
13.2 Key Raw Materials and Suppliers
13.2.1 Key Raw Materials Introduction
13.2.2 Key Suppliers of Raw Materials
13.3 Manufacturing Cost Structure Analysis
13.3.1 Production Process Analysis
13.3.2 Manufacturing Cost Structure of Immuno-Oncology
13.3.3 Raw Material Cost of Immuno-Oncology
13.3.4 Labor Cost of Immuno-Oncology
13.4 Major Distributors by Region
13.5 Customer Analysis

14 New Project Feasibility Analysis
14.1 Industry Barriers and New Entrants SWOT Analysis
14.2 Analysis and Suggestions on New Project Investment

15 Global Immuno-Oncology Market Revenue ($) and Sales Volume Forecast Segment by Type, Application and Region
15.1 Global Immuno-Oncology Revenue ($) and Sales Volume Forecast by Type (2025-2033)
15.1.1 Global Immuno-Oncology Revenue ($) Forecast by Type (2025-2033)
15.1.2 Global Immuno-Oncology Sales Volume Forecast by Type (2025-2033)
15.2 Global Immuno-Oncology Revenue ($) and Sales Volume Forecast by Application (2025-2033)
15.2.1 Global Immuno-Oncology Revenue ($) Forecast by Application (2025-2033)
15.2.2 Global Immuno-Oncology Sales Volume Forecast by Application (2025-2033)
15.3 Global Immuno-Oncology Sales Volume Forecast by Region (2025-2033)
15.4 Global Immuno-Oncology Revenue ($) Forecast by Region (2025-2033)

16 Research Findings and Conclusion